20 reasons why the Lucas Heights unviable production of medical isotopes is a sham and a dud.
The claim by Australian Nuclear Science and Technology Organisation (ANSTO) that it requires additional storage
capacity for intermediate level nuclear or radioactive waste at its Lucas Heights operations is completely false and consequently unjustified in all respects.
REASONS
- The present storage capacity at Lucas Heights is more than adequate for many years and even decades – this is the view of the Australian Radiation Protection and Nuclear Safety Agency (ARPANA) as the regulator and licensing authority
- The main undertaking representing 80% of its total operations and activity by ANSTO at Lucas Heights is the
production of nuclear medicineThe main undertaking representing 80% of its total operations and activity by ANSTO at Lucas Heights is theproduction of nuclear medicine - Only some 10% of this production annually is for local use in Australia
- The remainder is sold overseas but it is a very limited market
- The predominant purchasers of this production of nuclear medicine are third world countries
- These countries cannot afford to pay ANSTO for this nuclear medicine and hence it is treated as additional foreign aid by Australia
- The manufacture of nuclear medicine even in fully and proper commercial circumstances is a large loss making proposition
- It is estimated from authoritative overseas research that revenue from isotope production for nuclear medicine would likely offset only approximately 10% to 15% of the costs of the reactor used for the production and this does not include all the other costs associated with the production
9. Added to this ANSTO is regarded by world standards as an extremely high cost manufacturer of nuclear medicine
- ANSTO is fully funded as to its existence and operations by the federal government
11. On top of this ANSTO has proved to be a less than efficient producer of nuclear medicine due to the instances of shutting down of its reactor at Lucas Heights
- When this has occurred ANSTO purchased the nuclear medicine isotopes from overseas which has proved to be more efficient and cheaper than local production
- It was reported that ANSTO received $238 million last year as its annual funding from the federal government
- ANSTO because of this funding has no incentive or need to achieve profitability particularly in its production of nuclear medicine which represents its major undertaking and operational activity
- In any case there is a strong move in medicine throughout the world away from using nuclear medicine in all diagnosis and treatment due to its harmful nature
- Some countries are virtually banning nuclear medicine both in its manufacture and its use locally and for export because of its inherent dangerous nature
- An alternative permanent disposal would be better.
- The indisputable conclusion internationally is that the use of nuclear medicine generated by reactors is rapidly declining to a level where its future production will no longer be viable
- In view of the foregoing there are no justifiable or valid reasons or pretext for :
(a) the continued production by ANSTO of nuclear medicine by using a nuclear reactor for whatever reasons at Lucas Heights or elsewhere in Australia;
(b) the continuing loss making production of nuclear medicine by ANSTO at Lucas Heights for export overseas;
(c) the need to increase the storage capacity at Lucas Heights for intermediate level waste generated by the production of nuclear medicine; and
20 No pretext for the establishment whatsoever of the nuclear waste management facility by the federal government at Napandee
No comments yet.
Leave a Reply